Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Diabetic Gastroparesis Efficacy/Safety Study of TZP-102 (DIGEST)

This study has been terminated.
(Insufficient efficacy in planned interim futility analysis)
Information provided by (Responsible Party):
Tranzyme, Inc. Identifier:
First received: August 10, 2012
Last updated: December 18, 2012
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2013
  Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):